These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 8918614

  • 21. Diabetic glomerulopathy in man and experimental animal models.
    Steffes MW, Mauer SM.
    Int Rev Exp Pathol; 1984; 26():147-75. PubMed ID: 6400512
    [No Abstract] [Full Text] [Related]

  • 22. Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment.
    Aunapuu M, Pechter U, Arend A, Suuroja T, Ots M.
    Medicina (Kaunas); 2003; 39(10):975-9. PubMed ID: 14578640
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Glomerular cell proteoglycans: their possible role in progressive glomerular disease.
    Davies M.
    Exp Nephrol; 1995; 3(2):122-6. PubMed ID: 7773631
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hypoplastic tubules occurring in diffuse mesangial sclerosis.
    Shimamura T, Weiss LS.
    Pathol Int; 1996 Nov; 46(11):904-6. PubMed ID: 8970202
    [No Abstract] [Full Text] [Related]

  • 28. Reversible renal failure in focal glomerular sclerosis.
    Nagase S, Terasaki T, Sano M, Inage H, Koyama A, Narita M, Tojo S.
    Nihon Jinzo Gakkai Shi; 1986 Sep; 28(9):1197-203. PubMed ID: 3820831
    [No Abstract] [Full Text] [Related]

  • 29. The development of focal segmental glomerulosclerosis in masugi nephritis is based on progressive podocyte damage.
    Shirato I, Hosser H, Kimura K, Sakai T, Tomino Y, Kriz W.
    Virchows Arch; 1996 Nov; 429(4-5):255-73. PubMed ID: 8972762
    [Abstract] [Full Text] [Related]

  • 30. Pathogenesis of nonimmune glomerulopathies.
    Kwoh C, Shannon MB, Miner JH, Shaw A.
    Annu Rev Pathol; 2006 Nov; 1():349-74. PubMed ID: 18039119
    [Abstract] [Full Text] [Related]

  • 31. Mechanisms of disease: focal segmental glomerulosclerosis.
    Meyrier A.
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
    [Abstract] [Full Text] [Related]

  • 32. [Glomerulosclerosis: pathogenetic mechanisms and possibility of regression].
    Faraggiana T, Giannakakis C.
    G Ital Nefrol; 2008 Nov; 25 Suppl 44():S27-S32. PubMed ID: 19048583
    [Abstract] [Full Text] [Related]

  • 33. Internephron heterogeneity of growth factors and sclerosis.
    Fogo A.
    Kidney Int Suppl; 1994 Feb; 45():S24-6. PubMed ID: 8158892
    [No Abstract] [Full Text] [Related]

  • 34. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility.
    Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, Unanue ER, Shaw AS.
    Science; 2003 May 23; 300(5623):1298-300. PubMed ID: 12764198
    [Abstract] [Full Text] [Related]

  • 35. [Glomerular disease caused by solvents: an emerging problem].
    Bertelli G, Farina G, Alessio L.
    Med Lav; 1982 May 23; 73(3):175-86. PubMed ID: 6752680
    [No Abstract] [Full Text] [Related]

  • 36. Renal lesions of the FGS strain of mice: a spontaneous animal model of progressive glomerulosclerosis.
    Yoshida F, Matsuo S, Fujishima H, Kim HK, Tomita T.
    Nephron; 1994 May 23; 66(3):317-25. PubMed ID: 8190185
    [Abstract] [Full Text] [Related]

  • 37. [The fate of podocytes in proteinuric nephropathies].
    Ortiz A, Marrón B, Ramos A.
    Nefrologia; 2002 May 23; 22(5):425-31. PubMed ID: 12497743
    [No Abstract] [Full Text] [Related]

  • 38. Pathways leading from glomerular injury to glomerulosclerosis.
    Schreiner GF.
    Contrib Nephrol; 1990 May 23; 86():1-14; discussion 15-8. PubMed ID: 2078945
    [No Abstract] [Full Text] [Related]

  • 39. Effects of calcium channel blockers on experimental glomerular injury.
    Dworkin LD.
    J Am Soc Nephrol; 1990 Sep 23; 1(3 Suppl 1):S21-7. PubMed ID: 16989074
    [Abstract] [Full Text] [Related]

  • 40. Idiopathic focal segmental glomerulosclerosis.
    Schnaper HW.
    Semin Nephrol; 2003 Mar 23; 23(2):183-93. PubMed ID: 12704578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.